Another study that included 54 patients who underwent prophylactic gastrectomy for the CDH1 gene mutation and were followed on average for over 4 years concluded that this intervention is safe when performed in reference centers, and the postoperative quality of life is good despite the presence of persistent nutritional disorders [44]. This evidence concerns the gene CDH1 and nutritional disorder.